Publicaciones en colaboración con investigadores/as de University of Manchester (176)

2024

  1. Patients’ and caregivers’ perspective on challenges and outcomes with tube feeding: Analysis of home enteral nutrition survey data

    Clinical Nutrition ESPEN, Vol. 61, pp. 94-100

2023

  1. A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom

    Cancers, Vol. 15, Núm. 23

  2. A multi-national survey of experience and attitudes towards managing catheter related blood stream infections for home parenteral nutrition

    Clinical Nutrition ESPEN, Vol. 57, pp. 126-130

  3. A second update on mapping the human genetic architecture of COVID-19

    Nature

  4. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

    Genome Medicine, Vol. 15, Núm. 1

  5. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

  6. Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study

    BMJ open, Vol. 13, Núm. 7, pp. e075197

  7. EAACI guidelines on the diagnosis of IgE-mediated food allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 12, pp. 3057-3076

  8. Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

    Nature Medicine, Vol. 29, Núm. 9, pp. 2259-2267

  9. Extracorporeal Techniques in End-Stage Kidney Disease

    Blood Purification

  10. How to deal with micronutrient product shortage - Editorial

    Clinical Nutrition

  11. Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol

    Frontiers in Neurorobotics, Vol. 17

  12. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet, Vol. 401, Núm. 10391, pp. 1853-1865

  13. Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours

    European Journal of Cancer, Vol. 188, pp. 39-48

  14. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

    The Lancet, Vol. 401, Núm. 10378, pp. 733-746

  15. Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

    New England Journal of Medicine, Vol. 389, Núm. 22, pp. 2063-2075

2022

  1. Code of practice needed for samples donated by trial participants

    The Lancet Oncology

  2. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

    Breast Cancer Research, Vol. 24, Núm. 1

  3. Contemporary treatment patterns and response in relapsed/refractory cutaneous T-cell lymphoma (CTCL) across five european countries

    Cancers, Vol. 14, Núm. 1

  4. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

    Annals of Oncology, Vol. 33, Núm. 5, pp. 466-487